Bioethics

  • Home
  • About
  • Events
  • Bioethics Resources
    • Featured Articles
    • Academic Programs & Certificates
    • Bioethics Centers & Institutions
    • Bioethics Journals & Publications
    • Multimedia Resources
    • Bioethics 101 Resources
    • Book Reviews
    • Movie Reviews
    • Employment, Fellowships & Internships
  • Topics

Your global information source on bioethics news, issues, & events

  • Twitter
  • RSS
  • Artificial Intelligence
  • Biotech
  • Clinical / Medical
  • Cloning
  • Covid-19
  • Culture
  • Disability Ethics
  • Disaster Ethics
  • Education
  • Emerging Technologies
  • Employment / Fellowships / Internships
  • End of Life
  • Eugenics
  • Euthanasia / Suicide
  • Genetic Ethics
  • Geriatric & Aging
  • Global Bioethics
  • Healthcare
  • Human Dignity
  • Human Enhancement
  • Informed Consent
  • Journal Articles
  • Medical Tourism
  • Mental Health
  • Multimedia Resources
  • Nanotechnology
  • Neuroethics
  • Nursing
  • Organ Donation / Transplantation
  • Pediatric
  • Pharma
  • Public Health
  • Public Policy
  • Reproductive Ethics
  • Research Ethics
  • Reviews
  • Stem Cell Research
  • Synthetic Biology
  • Women's Health
Pharma

Pharma

October 1, 2026

How Did Christa Pike Survive Two Lethal Injections of Pentobarbital?

(NYT) – A catheter carrying the drug may not have delivered the doses to Ms. Pike’s bloodstream, experts said. The drug itself may have been degraded. The execution team went through at least seven needles trying to find a vein … Read More

Posted by Bioethics Pundit

Posted in Clinical / Medical, highlights, News, Pharma



 
 

October 1, 2026

The Next Frontier for Obesity Drugs Isn’t How Much Weight You Lose, but What Kind

(WSJ) – Drugmakers targeting muscle preservation and fat loss as they build next generation of weight-loss medications For as long as drugmakers have been testing weight-loss drugs, the question has been: How much weight do people lose? Now it is … Read More

Posted by Bioethics Pundit

Posted in News, Pharma



 
 

September 25, 2026

What GLP-1 users should know about the potential risk of a rare type of vision loss

(ABC News) – Dozens of Americans have filed personal injury lawsuits against the makers of popular GLP-1 drugs, like Ozempic, Wegovy and Mounjaro, claiming they were not properly warned of the risk of a rare type of sudden vision loss, … Read More

Posted by Bioethics Pundit

Posted in highlights, Informed Consent, News, Pharma



 
 

September 23, 2026

A new battery could make edible electronics safer

(The Economist) – Its components dissolve once it has done its job DEVICES THAT peer into the human body from the outside, like X-ray scanners and MRI machines, have transformed medicine. A new generation of ingestible sensors could do the … Read More

Posted by Bioethics Pundit

Posted in Emerging Technologies, News, Pharma



 
 

September 21, 2026

Novo Nordisk Will Use Anthropic’s Claude for Drug Research

(WSJ) – The Ozempic maker is partnering with the artificial-intelligence firm to speed up drug development Novo Nordisk, the Danish drugmaker behind blockbuster diabetes and weight-loss drugs Ozempic and Wegovy, is partnering with Anthropic to use artificial intelligence for drug … Read More

Posted by Bioethics Pundit

Posted in Artificial Intelligence, highlights, News, Pharma, Research Ethics



 
 

September 16, 2026

Those Viral Bodega Peptides Aren’t Actually Peptides

(Wired) – WIRED tested samples of four types of peptides. The results show how lightly regulated the industry is, even as popularity surges. WIRED sent the vials to Finnrick, an Austin-based startup that offers independent peptide testing. Consumers can request … Read More

Posted by Bioethics Pundit

Posted in Informed Consent, News, Pharma



 
 

September 15, 2026

Drug firms’ secret data supercharge AI protein models

(Nature) – An AI system trained on more than 20,000 protein structures from pharmaceutical companies outperforms AlphaFold-like models that use only public data. For drug discovery, protein-folding models such as AlphaFold have a problem: there aren’t enough data in public … Read More

Posted by Bioethics Pundit

Posted in Artificial Intelligence, Emerging Technologies, highlights, News, Pharma, Research Ethics



 
 

September 14, 2026

A Teen Autopsy Marks the Arrival of a Deadly Drug in San Francisco

(NYT) – City officials — and one determined mother — are working to stop the spread of cychlorphine, which is far more potent than fentanyl. The death occurred in Ms. Lacourte’s three-bedroom apartment in the affluent Lower Nob Hill neighborhood … Read More

Posted by Bioethics Pundit

Posted in highlights, News, Pharma, Public Health



 
 

September 14, 2026

One State’s Battle to Stop People From Taking Unapproved Weight-Loss Drugs

(WSJ) – As bootleg versions of an experimental drug from Eli Lilly flood the market, regulators try to curb supply Clinics and medspas, promising people transformational weight loss, have figured out how to procure and sell an experimental drug that … Read More

Posted by Bioethics Pundit

Posted in highlights, Informed Consent, News, Pharma



 
 

September 11, 2026

The Race for the Next Big Weight-Loss Drug Is On—and China Wants In

(WSJ) – Long a maker of low-end generic drugs, the country is now home to biotech firms that are innovating fast Today Eli Lilly and Novo Nordisk, with drugs like Mounjaro and Ozempic, are the undisputed leaders of the $80-billion … Read More

Posted by Bioethics Pundit

Posted in Global Bioethics, highlights, News, Pharma



 
 

September 10, 2026

Early Data Indicates an A.I.-Generated Drug Could Slow Aging

(NYT) – Artificial intelligence was used to help develop a drug candidate, rentosertib, for a rare lung condition. Its maker says the drug also seems to reduce the biological hallmarks of age. Last year, a clinical trial conducted by Insilico … Read More

Posted by Bioethics Pundit

Posted in Artificial Intelligence, Emerging Technologies, highlights, Human Enhancement, News, Pharma



 
 

September 8, 2026

Another Heart Drug Fails, Shocking Cardiologists

(NYT) – Doctors were hopeful the drug, which was being tested in a large clinical trial by Novartis, was going to be a powerful new tool to fight heart disease. Novartis announced on Friday that its experimental drug, pelacarsen, widely … Read More

Posted by Bioethics Pundit

Posted in Clinical / Medical, News, Pharma



 
 

September 7, 2026

Study Suggests AI-Generated Drug Could Slow Aging

(Gizmodo) – An AI-generated drug showed early signs of potentially slowing aging, according to a new study out today in Nature Biotechnology, possibly taking the first small step towards using AI to cure all the diseases tech companies companies keep … Read More

Posted by Bioethics Pundit

Posted in Artificial Intelligence, highlights, News, Pharma, Research Ethics



 
 

September 3, 2026

The HIV clinics that disappeared when American aid stopped

(Daily Nation) – For years, in various counties, small, low-profile HIV clinics operated almost like a separate world within Kenya’s health system, funded not by the National Treasury but by the United States government, and built, deliberately, to keep a … Read More

Posted by Bioethics Pundit

Posted in Clinical / Medical, Global Bioethics, highlights, News, Pharma, Public Health



 
 

September 2, 2026

China is changing the shape of global health. The terms are still up for negotiation

(Nature) – China is making waves in global health care. The country’s biotechnology companies are producing medicines at a speed and cost that has drawn interest from the world’s largest pharmaceutical groups. They manufacture drugs and medical equipment used across … Read More

Posted by Bioethics Pundit

Posted in Clinical / Medical, Global Bioethics, News, Op-Ed, Pharma



 
 

September 2, 2026

Inside the Perimenopause Industrial Complex

(Wired) – How an alliance of tech startups, MAHA operatives, and actual medical experts made millennial women the new face of hormone therapy. One might be forgiven for wondering what isn’t a symptom of perimenopause. No lab test can reveal … Read More

Posted by Bioethics Pundit

Posted in Clinical / Medical, highlights, Mental Health, News, Pharma, Women's Health



 
 

September 1, 2026

Psilocybin Might Make Your Brain Live in the Moment

(Wired) – Psychedelics are often associated with disconnecting from reality, but a recent neuroimaging study found that psilocybin can actually make our brain activity more attuned to the world around us. Under the influence of psychedelics, the usual organization of … Read More

Posted by Bioethics Pundit

Posted in Neuroethics, News, Pharma, Research Ethics



 
 

August 31, 2026

A $480,000-a-Year Pill Reflects a New Normal for Cancer Drugs

(NYT) – Rasonque, the new pancreatic cancer treatment from Revolution Medicines, illustrates the huge inflation in cancer drug prices over the past two decades. Revolution Medicines set a sticker price of about $480,000 a year, or $663 a tablet, for … Read More

Posted by Bioethics Pundit

Posted in highlights, News, Pharma



 
 

August 28, 2026

Will muscle-boosting meds be the next big thing after GLP-1 drugs?

(New Scientist) – A number of drugs designed to prevent muscle loss and boost muscle growth are being tested in clinical trials. Columnist Michael Le Page looks at whether building and maintaining muscles is about to get a whole lot … Read More

Posted by Bioethics Pundit

Posted in Biotech, Human Enhancement, News, Pharma



 
 

August 27, 2026

FDA approves landmark pancreatic cancer drug that’s shown to improve survival

(AP) – The Food and Drug Administration on Wednesday approved a groundbreaking new drug for advanced pancreatic cancer, offering U.S. patients a more effective treatment against one of the deadliest types of cancer. FDA officials gave expedited approval to the … Read More

Posted by Bioethics Pundit

Posted in highlights, News, Pharma



 
 

August 25, 2026

The Ruthless Efficiency of Ultrapotent Street Drugs

(NYT) – Five decades after the “war on drugs” sought to make substance abuse unaffordable, illicit drugs are cheaper and more powerful than ever. A visit to Baltimore shows why. Because lab-made drugs are so easily mixed and altered, their … Read More

Posted by Bioethics Pundit

Posted in News, Pharma, Public Health



 
 

August 25, 2026

Baby Boomers Are Smoking More Pot. Their Neighbors Are Fuming.

(WSJ) – Cannabis critics feel trapped in a haze of frustration. It’s leading to legal threats, cop calls and arguments straight out of high school. Seniors are among the fastest-growing demographics for marijuana use in the U.S., taking the drug … Read More

Posted by Bioethics Pundit

Posted in Geriatric & Aging, highlights, Informed Consent, Mental Health, Neuroethics, News, Pharma



 
 

August 24, 2026

When AI designs a drug, who gets the credit?

(MIT Technology Review) – Patents can only name humans as inventors. For now. Insilico leads a pack of companies using AI to rapidly come up with drug ideas humans might never think of, potentially speeding the race to new cures. … Read More

Posted by Bioethics Pundit

Posted in Artificial Intelligence, Biotech, highlights, News, Pharma



 
 

August 21, 2026

The meds that can make the heat harder to handle

(BBC) – Some of the most prescribed medications, including those used to treat depression, ADHD and high blood pressure, can increase the risk of dehydration and other heat-related conditions. Many types of drugs used to treat mental health conditions, including … Read More

Posted by Bioethics Pundit

Posted in News, Pharma, Public Health



 
 

August 19, 2026

Moderna’s Road to a Cancer Vaccine

(WSJ) – Moderna got a shot in the arm Wednesday after reporting that its personalized melanoma vaccine succeeded, in a large late-stage trial, at preventing cancer from coming back in high-risk patients. Investors cheered, as the company’s stock soared 177%. … Read More

Posted by Bioethics Pundit

Posted in Clinical / Medical, Genetic Ethics, highlights, News, Op-Ed, Pharma



 
 
Older posts
  • Recent News
  • Trending
  • 10/01/2026How Did Christa Pike Survive Two Lethal Injections of Pentobarbital?
  • 10/01/2026AI agents have a normal-people problem
  • 10/01/2026Religious Scholars Met With Anthropic. What They Heard Stunned Them.
  • 10/01/2026When AI Tells a Story About Your Health, Is It True?
  • 10/01/2026FTC probes OpenAI and Anthropic over AI safety
More News
    • Artificial Intelligence
    • Biotech
    • Clinical / Medical
    • Cloning
    • Covid-19
    • Culture
    • Disability Ethics
    • Disaster Ethics
    • Education
    • Emerging Technologies
    • Employment / Fellowships / Internships
    • End of Life
    • Eugenics
    • Euthanasia / Suicide
    • Genetic Ethics
    • Geriatric & Aging
    • Global Bioethics
    • Healthcare
    • Human Dignity
    • Human Enhancement
      • Transhumanism
    • Informed Consent
    • Journal Articles
    • Medical Tourism
    • Mental Health
    • Multimedia Resources
    • Nanotechnology
    • Neuroethics
    • News
      • Op-Ed
    • Nursing
    • Organ Donation / Transplantation
    • Pediatric
    • Pharma
    • Public Health
    • Public Policy
    • Reproductive Ethics
    • Research Ethics
    • Reviews
      • Books
      • Movies
    • Stem Cell Research
    • Synthetic Biology
    • Women's Health
    Ad
    bioethics.com
    • Home
    • About
    • Events
    • Contact
    • Advertising

    bioethics.com © 2002–Present by CBHD is licensed under CC BY-NC-ND 4.0

    • Twitter
    • RSS

    A Project Of The Center for Bioethics & Human Dignity